1. Home
  2. PODD vs COO Comparison

PODD vs COO Comparison

Compare PODD & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$215.93

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

HOLD

Current Price

$71.42

Market Cap

16.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PODD
COO
Founded
2000
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
16.5B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
PODD
COO
Price
$215.93
$71.42
Analyst Decision
Strong Buy
Buy
Analyst Count
20
11
Target Price
$357.65
$90.18
AVG Volume (30 Days)
839.7K
1.9M
Earning Date
05-07-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.48
0.66
Revenue
$2,708,100,000.00
$2,532,800,000.00
Revenue This Year
$24.33
$6.66
Revenue Next Year
$19.33
$5.20
P/E Ratio
$64.99
$106.99
Revenue Growth
30.73
18.41
52 Week Low
$216.49
$61.78
52 Week High
$354.88
$89.83

Technical Indicators

Market Signals
Indicator
PODD
COO
Relative Strength Index (RSI) 29.20 33.78
Support Level N/A $70.97
Resistance Level $299.75 $75.61
Average True Range (ATR) 7.61 2.03
MACD -0.52 -0.25
Stochastic Oscillator 1.66 25.73

Price Performance

Historical Comparison
PODD
COO

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Share on Social Networks: